ANAB

AnaptysBio, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$57.68

Market Cap

$1.66B

Beta

0.41

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+157.01%

EPS Growth (YoY)+90.11%

Revenue CAGR 3Y+183.58%

P/E Ratio0.0

PEG Ratio—

FCF Yield+1.18%

Debt / Equity7.81

Interest Coverage0.6x

No credit card required

Already have an account? Sign in to view the full analysis for ANAB.